Huntington’s disease
Ipsen forges $1bn alliance with Exicure on neurodegenerative diseases
Phil Taylor
Angelman Syndrome, Exicure, Huntington's disease, Ipsen, neurodegenerative disease, partnering, rare disease
0 Comment
Roche stops dosing in trial of Huntington’s disease hopeful tominersen
Richard Staines
Huntington's disease, Ionis, neurology, Roche
0 Comment
UniQure presses go on Huntington’s gene therapy trial
Phil Taylor
gene therapy, Huntington's disease, rare disease, uniQure
0 Comment
Sanofi hands back neurology gene therapy rights to Voyager
Richard Staines
Huntington's disease, neurology, R&D, Sanofi, Voyager Therapeutics
0 Comment
News/ News/ R&D/ Roche/ Top pharmaceutical companies/ UK & Europe
New Huntington’s drug granted priority designation
Joy Persaud
European Medicines Agency, Huntington's disease, Roche
0 Comment
Roche takes on development of potential Huntington’s breakthrough
Andrew McConaghie
antisense drugs, Huntington's disease, Ionis Pharmaceuticals
0 Comment
Digital and Social Media/ News/ Teva
Huntington’s Disease wearable gets backing from NIH
Marco Ricci
BioSensics, digital health, Huntington's disease, Teva, wearables
0 Comment
BioSensics’ HDWear provides real-time motor function scores in Huntington’s patients.
FDA approves Teva’s Huntington’s Disease drug
Richard Staines
fda, Huntington's disease, neurology, orphan disease, Teva
0 Comment
First treatment approved for Huntington’s Disease in almost a decade.